An Antimicrobial Peptidomimetic Induces Mucorales Cell Death through Mitochondria-Mediated Apoptosis by Barbu, E. Magda et al.
 An Antimicrobial Peptidomimetic Induces Mucorales Cell Death
through Mitochondria-Mediated Apoptosis
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Barbu, E. Magda, Fazal Shirazi, Danielle M. McGrath, Nathaniel
Albert, Richard L. Sidman, Renata Pasqualini, Wadih Arap, and
Dimitrios P. Kontoyiannis. 2013. “An Antimicrobial
Peptidomimetic Induces Mucorales Cell Death through
Mitochondria-Mediated Apoptosis.” PLoS ONE 8 (10): e76981.
doi:10.1371/journal.pone.0076981.
http://dx.doi.org/10.1371/journal.pone.0076981.
Published Version doi:10.1371/journal.pone.0076981
Accessed February 19, 2015 2:43:45 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11878963
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
An Antimicrobial Peptidomimetic Induces Mucorales Cell
Death through Mitochondria-Mediated Apoptosis
E. Magda Barbu1,2, Fazal Shirazi2, Danielle M. McGrath1¤a, Nathaniel Albert2, Richard L. Sidman3,4, Renata
Pasqualini1*¤b, Wadih Arap1*¤b, Dimitrios P. Kontoyiannis2*
1 David H. Koch Center, Department of Genitourinary Medical Oncology, the University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
of America, 2 Department of Infectious Diseases, the University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America, 3 Harvard
Medical School, Boston, Massachusetts, United States of America, 4 Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts,
United States of America
Abstract
The incidence of mucormycosis has dramatically increased in immunocompromised patients. Moreover, the array of
cellular targets whose inhibition results in fungal cell death is rather limited. Mitochondria have been mechanistically
identified as central regulators of detoxification and virulence in fungi. Our group has previously designed and
developed a proteolytically-resistant peptidomimetic motif D(KLAKLAK)2 with pleiotropic action ranging from targeted
(i.e., ligand-directed) activity against cancer and obesity to non-targeted activity against antibiotic resistant gram-
negative rods. Here we evaluated whether this non-targeted peptidomimetic motif is active against Mucorales. We
show that D(KLAKLAK)2 has marked fungicidal action, inhibits germination, and reduces hyphal viability. We have
also observed cellular changes characteristic of apoptosis in D(KLAKLAK)2-treated Mucorales cells. Moreover, the
fungicidal activity was directly correlated with vacuolar injury, mitochondrial swelling and mitochondrial membrane
depolarization, intracellular reactive oxygen species accumulation (ROS), and increased caspase-like enzymatic
activity. Finally, these apoptotic features were prevented by the addition of the ROS scavenger N-acetyl-cysteine
indicating mechanistic pathway specificity. Together, these findings indicate that D(KLAKLAK)2 makes Mucorales
exquisitely susceptible via mitochondrial injury-induced apoptosis. This prototype may serve as a candidate drug for
the development of translational applications against mucormycosis and perhaps other fungal infections.
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Introduction
Mucormycosis, infection caused by the Mucorales fungi, is
second in frequency only to aspergillosis, and affects mainly
severely immunocompromised individuals, especially those
with malignancies and hematologic stem-cell or solid-organ
transplants [1,2]. In this critically-ill patient population, the
mortality rates exceed 50% when brain or lungs are the major
targets and 90% with disseminated infections [1-3]. Mucorales
are notoriously resistant to most antifungals, except to toxic
agents such as polyene amphotericin B (AMB) and triazole
posaconazole, and even these agents are relatively inefficient
unless administered very early in the invasive stage, when
fungal infection is often very difficult to recognize [4,5]. The
genomic sequencing of the most common cause of invasive
mucormycosis, Rhizopus oryzae, has suggested that
Mucorales innate resistance to therapy is the result of a
duplication within the genome of ergosterol biosynthesis
pathway genes and mitochondrial protein complexes
associates with respiratory electron transport chains [6].
Hence, development of new antifungal agents with distinct
mechanisms-of-action against mucormycosis, especially those
targeting the above mentioned pathways, clearly remains a
major unmet need of contemporary medicine.
Antimicrobial peptides, a first line of defense of all species,
have been long considered excellent models for antibiotic and
antifungal drug development [7]. This vast group of molecules
(>1,200) targets a wide spectrum of pathogens and
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demonstrates effective neutralizing activity [7]. Although most
of these peptides presumably act through cell membrane
permeabilization, recent reports have emphasized additional
functions, including immunomodulatory and wound-healing
activities [8]. Notably, peptides displaying selective toxicity
against fungi have also been reported: a recent example is the
lipopeptide echinocandins, that inhibit the activity of 1,3 β-
glucan synthase, an enzyme vital for fungal wall synthesis [9];
however, despite their tentatively broad and specific
mechanism of action, these peptides have no activity against
Mucorales species [9].
Despite the potential of antimicrobial peptides as drugs,
translational development has been hindered mainly by their
poor pharmacokinetic attributes, especially their rapid
proteolytic degradation along with high manufacturing costs
[10]. Attempts to engineer more effective synthetic mimics have
focused on the substitution of non-natural D- or β-amino acid
residues for the normal L-residues, a process that renders
peptidomimetics resistant to proteolysis [11-13]. Studies from
our group and others have established that peptide-targeted
(i.e., ligand-directed) drugs containing the all-D-enantiomer,
D(KLAKLAK)2, are effective therapeutic candidates for cancer
and obesity [14-22]. We have also recently shown that the non-
targeted version of this peptidomimetic per se maintains its
value as an antimicrobial and retains its membrane-disrupting
activity against Gram-negative bacteria, independently of
bacterial growth stage or preexisting antibiotic resistance [23].
In the work presented here, we show that D(KLAKLAK)2: (i) is
strongly active against Mucorales, (ii) induces cell and
mitochondrial membrane disruption and depolarization, and (iii)
triggers fungal cell death specifically through a reversible
apoptotic mechanistic pathway. Collectively, our data indicate
that D(KLAKLAK)2 has great potential for development of
translational applications in vivo against mucormycosis, a
frequent and inherently challenging infection in critical patients.
Materials and Methods
Drugs and peptidomimetics
AMB (5 mg/ml; Sigma), FLU (2 mg/ml; Sigma), streptomycin
(50 mg/ml; Sigma), colistin sulfate (15 mg/ml; Sigma),
D(KLAKLAK)2 , and D(CVRAC) (100 mg/ml; PolyPeptide
Laboratories) were commercially obtained and prepared in
sterile water with aliquots stored at -20°C until use. AMB
served as a positive control at one-half MIC (2 µg/ml) or MIC (4
µg/ml) [24], FLU and D(CVRAC) served as negative controls at
128 µg/ml and 300 µg/ml, respectively. Colistin served as a
positive control for the ATP efflux assay at 32 µg/ml [24].
Isolates and growth conditions
Clinical isolates were grown on yeast extract agar glucose
(YAG) plates. After 48 hours at 37°C, spores were collected in
sterile saline containing 0.08% Tween-20, washed twice in
saline, filtered and enumerated in a hemocytometer. Spores
were stored at 4°C in phosphate-buffered saline (PBS)
containing streptomycin (100 µg/ml). Spores where grown to
germlings or mycelia in RPMI 1640 buffered with MOPS (3-[N-
morpholino] propanesulfonic acid) at a final concentration of
0.165 mol/L at pH 7.0 with glutamine and without bicarbonate.
Susceptibility testing
Broth microdilution was performed as recommended by the
Clinical and Laboratory Standards Institute (CLSI) guidelines
[25]. To determine the minimum fungicidal concentration
(MFC), an aliquot (20 µl) taken from each well that showed
100% growth inhibition and from the last well showing growth
similar to that in the control well were plated onto YAG plates.
After 24 hours incubation at 37°C, the MFC was registered as
the lowest drug concentration at which no growth was
observed.
Germination assay
To determine whether D(KLAKLAK)2 affects spore
germination, we suspended spores (105/ml) in drug-containing
RPMI 1640. After six hours, an aliquot (1 ml) was removed
from the culture. Organisms were collected by centrifugation at
13,000 x g for five min, washed one time in PBS and fixed in
100 µl of PBS containing 4% paraformaldehyde. The formation
of germlings was determined by bright field microscopy
(Olympus IX-70; Olympus, Melville, NY) at 400-fold
magnification [24].
Post-antifungal effect
To determine the delay in logarithmic growth upon exposure
to D(KLAKLAK)2, we exposed spores (106/ml) to drug-
containing RPMI 1640 for one hour, washed three times in PBS
and re-suspended in drug-free RPMI 1640. The logarithmic
growth in RPMI 1640 was subsequently determined by
measuring the OD405 nm every 20 min for the first hour of
incubation at 37°C and every hour afterwards. The post-
antifungal effect interval was calculated as the difference
between the lag time of each drug concentration and the lag
time of the free-drug well [26].
Viability assay
To assess the fungicidal effect of D(KLAKLAK)2, spores
(104/ml) were grown to mycelia in microcentrifuge tubes with
RPMI 1640 containing 0.15% (wt/vol) Junlon (Nihon Junyaku,
Tokyo, Japan) at 37°C with shaking for 18 hours. Medium was
removed by centrifugation at 13,000 x g and mycelia were re-
suspended in RPMI 1640 containing test drugs for 6 hours.
Next, mycelia were washed twice in 0.1 M 3-(N-morpholino)
propanesulfonic acid, pH 7 (MOPS buffer) to remove drugs,
and incubated with bis-(1,3-dibutylbarbituric acid) trimethine
oxonol (DiBAC; Molecular Probes) at 2 µg/ml final
concentration, as described [24]. After one hour, samples were
washed twice in MOPS buffer and mycelia were mounted on
glass slides. Images were acquired by using a fluorescent
microscope (Olympus BX-71; Olympus, Melville, NY) with a
fluorescein isothiocyanate (FITC) filter at 400-fold
magnification.
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XTT reduction assay
We measured the extent of hyphal damage over time upon
exposure to D(KLAKLAK)2 with the 2,3-bis[2-methyloxy-4-
nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-5-
carboxanilide] (XTT) formazan reduction assay as described
[27,28]. To obtain mycelia, R. oryzae and M. circinelloides
spores (104/ml) were suspended in RPMI 1640, dispensed into
96-well microtiter plates (100 µl/well) and incubated at 37°C for
18 hours. Drugs diluted in RPMI 1640 were then added to the
wells (100 µl/well), and incubated at 37°C. Drug-free RPMI
1640 served as the control medium. After 0, 2, 4, 6, or 24
hours, 1 mg of XTT and 0.17 mg of menadione (Sigma) were
added to each well. Plates were incubated at 37°C for an
additional hour, and absorbance was measured at OD450 nm.
Hyphal viability for each time point and drug concentration was
calculated as percent of the control well (set to a value of
100%).
ATP release assay
We assessed the severity of D(KLAKLAK)2-induced
membrane damage by amount of cellular ATP released into the
medium. R. oryzae or M. circinelloides spores were
enumerated in a hemacytometer and suspended in RPMI 1640
at 107 cells/ml. After six hours of incubation at 37°C, the
medium was removed by centrifugation at 13,000 x g for five
min and germlings were re-suspended in drug-containing or
drug-free RPMI 1640. After 5, 30, 60, and 90 min of incubation,
germlings were removed by centrifugation as described above
and the ATP released in the supernatants was assayed by
using the CellTiter-Glo luminescent kit (Promega). Data were
recorded with a microplate luminometer (Spectramax M5;
Molecular Devices) [25,29].
Transmission electron microscopy
R. oryzae spores (106 /ml) were grown for five hours at 37°C.
After the generation of germlings was observed by bright field
microscopy, drugs were added to the cultures and incubated at
37°C for an additional hour. The ultrastructural changes in
germlings features induced by the presence of drugs compared
to antifungal-free controls were assessed by TEM at 6,000-fold
as described [24].
FM4-64 staining
Vacuolar morphological changes were visualized by staining
with the lipophilic styryl dye N-(3-triethylammoniumpropyl)-4-(p-
diethylaminophenylhexatrienyl)pyridinium dibromide (FM4-64)
(Invitrogen). R. oryzae hyphae were generated as described
above and incubated with FM4-64 at a final concentration of 5
µM for 30 min at RT. After removing the excess dye, hyphae
were re-suspended in drug-containing RPMI 1640 and
incubated for 60 min at 37°C with shaking. Hyphae were
collected, washed three times in PBS and mounted on glass
slides. Images were acquired under a triple-band fluorescent
microscope (Olympus BX-71; Olympus, Melville, NY) with a
rhodamine filter at 400-fold magnification [30].
MitoTracker staining
Mitochondria swelling was observed by staining with 2-[3-
[5,6-dichloro-1,3-bis[[4-(chloromethyl)phenyl]methyl]-1,3-
dihydro-2H-benzimidazol-2-ylidene]-1-propenyl]-3-methyl-,
Benzoxazolium chloride (MitoTracker Green FM) (Invitrogen).
R. oryzae spores were cultivated in RPMI 1640 at 37C°. After
six hours, the germlings were harvested and resuspended in
medium containing 200 nM MitoTracker for 30 min at 37C°.
The excess dye was removed by washing three times with 50
mM phosphate buffer, pH 6.0. Images of fixed germlings in
paraformaldehyde (4%) were acquired under the FITC filter at
400-fold magnification [31].
Detection of intracellular reactive oxygen species
Intracellular ROS levels in R. oryzae and M. circinelloides
germlings were measured as described [32]. Germlings were
treated with 150 µg/ml of D(KLAKLAK)2 for three hours at 37 °C,
and then spiked with DHR-123 (5 µg/ml). After two hours at RT,
the germlings were harvested at 13,000 x g for five min and
observed with a Nikon Microphot SA fluorescence microscope
(excitation, 490 nm; emission, 590 nm). For quantitative
assays, fluorescence intensity values were recorded by using a
POLARstar Galaxy microplate reader (excitation, 488 nm;
emission, 525 nm; BMG LABTECH, Offenburg, Germany). N-
acetyl cysteine (NAC) was used as a ROS scavenger at a final
concentration of 40 mM.
Mitochondrial membrane potential (ΔΨm)
measurements
Mitochondrial membrane depolarization was assessed by
staining with RH-123, a fluorescent dye that distributes in the
matrix in response to electric potential as described [32,33].
Briefly, germlings exposed to drugs for three hours at 37 °C
were harvested via centrifugation, washed twice, and re-
suspended in PBS. RH-123 was added to the final
concentration of 10 µM, and then the mixture was incubated for
30 min in the dark at RT. NAC was used as a ROS scavenger
at 40 mM final concentration. Fluorescence intensity was
measured as described above.
Cytochrome c release from mitochondria
cyt c release into the cytosol was performed as described
[32,34]. To isolate mitochondria, R. oryzae and M.
circinelloides germlings were allowed to grow for five hours at
37 °C. Germlings were then harvested and resuspended in
fresh RPMI broth containing either 150 µg/ml of D(KLAKLAK)2
or 2 µg/ml of AMB for three hours at 37 °C. Cells were
harvested by centrifugation at 5,000 × g for five min and the
pellet was homogenized in a 50 mM Tris, pH 7.5, 2 mM
ethylenediaminetetraacetic acid (EDTA), 1 mM
phenylmethylsulfonyl fluoride. Next, the admixture was
supplemented with 2% glucose and centrifuged at 2,000 x g for
10 min to remove cellular debris and unbroken cells. The
supernatant was collected, centrifuged at 30,000 × g for 45 min
and then used to estimate cyt c in cytoplasm. To obtain pure
mitochondria, the pellet was washed in 50 mM Tris (pH 5.0)
and 2 mM EDTA, incubated for five min, and centrifuged at
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5,000 x g for 30 seconds. Mitochondria were suspended in 2
mg/ml of Tris-EDTA buffer. After being reduced by 500 mg/ml
ascorbic acid at RT for five min, the amount of cyt c in the
cytosolic and mitochondrial fractions was measured at 550 nm
with a POLARstar Omega spectrophotometer (BMG
LABTECH, Ortenburg, Germany).
Detection of metacaspase activity
Activation of metacaspases was detected with the CaspACE
FITC-VAD-FMK In Situ Marker [35]. Germlings were pretreated
with drugs for three hours at 37°C. Cells were harvested,
washed in PBS, and then re-suspended in 10 µM CaspACE
FITC-VAD-FMK solution. After two hours of incubation at 30°C,
germlings were washed twice and re-suspended in PBS.
Samples were mounted and viewed in a Nikon fluorescence
microscope (emission, 488 nm; excitation, 520nm).
Statistical analysis
For all assays, three independent experiments were carried
out in triplicates. Comparisons of multiple treatment groups
were performed by using two-way analysis of variance with
post-hoc paired comparisons by Dunnett’s test.
Calculations were made with InStat (GraphPad Software).
Two-tailed P values of less than 0.05 were considered
statistically significant.
Results and Discussion
Mucorales are susceptible to D(KLAKLAK)2
In previous work, we demonstrated that D(KLAKLAK)2, a
proteolytically-resistant peptide-like motif, is active against
several Gram-negative rods, irrespective of their pre-existent
antibiotic resistance [23]. Cellular and model membrane assays
revealed that this peptidomimetic disrupts the lipid bilayer in a
detergent-like manner, resulting in death of bacteria due to
dissipation of proton-motive force [23]. Therefore, we
hypothesized that D(KLAKLAK)2 may have similar effect on
fungal membranes. Susceptibility testing by broth microdilution
[25] in RPMI 1640 revealed complete growth inhibition of
Mucorales clinical isolates (Table 1). The average minimum
inhibitory concentration (MIC) was 300 µg/ml and the minimum
fungicidal concentration (MFC) was twice the MIC (median
MFC/MIC ratio, 2) (Table 1). When yeast extract-agar-glucose
medium (YAG) was used, similar values were recorded for R.
oryzae. However, the MICs against Mucor circinelloides were
higher (~600 µg/ml) and an MFC value could not be
determined in these growth conditions (Table 1).
To further provide proof-of-concept that D(KLAKLAK)2 is
active against Mucorales, we examined its drug effect on
germination. After testing a range of D(KLAKLAK)2
concentrations (18.75-300 µg/ml), we determined that
germination of both R. oryzae and M. circinelloides was
reduced, starting at 75 µg/ml, and with complete inhibition
observed at 300 µg/ml. Notably, the activity of D(KLAKLAK)2 at
300 µg/ml concentration was similar to that of the gold-
standard drug AMB in regard to germination arrest (Figure 1A).
A negative control peptidomimetic D(CVRAC) [19] as well as
fluconazole (FLU), an azole with no activity against Mucorales,
had no detectable effect on the formation of germlings (Figure
1A).
Given that D(KLAKLAK)2 inhibited germination, we next
examined its activity against the invasive development form of
the fungus, the hyphae. We used an established 2,3-bis (2-
methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-
tetrazolium hydroxide (XTT) reduction assay, in which the
conversion of this compound to colored formazan in the
presence of metabolic activity correlates with cell survival and
growth [27,28]. We found a decrease by nearly 40% percent in
hyphal viability at one-half MIC (150 µg/ml) of D(KLAKLAK)2 for
both R. oryzae (Figure 1B) and M. circinelloides (Figure 1C).
Similar to AMB, exposure to D(KLAKLAK)2 at MIC
concentrations (300 µg/ml) resulted in ~70% reduction in
viability relative to untreated hyphae (p ≤ 0.0001). As expected,
the negative control peptidomimetic D(CVRAC) and FLU had no
detectable effect on hyphal development.
Finally, we assessed the ability of D(KLAKLAK)2 to induce a
post-antifungal effect. Spores exposure to the peptidomimetic
(300 µg/ml) for one hour resulted in a three hours delay in the
onset of the logarithmic growth for both R. oryzae (Figure 1D)
and M. circinelloides (Figure 1E) compared to that of
untreated-, FLU- or control peptidomimetic-exposed conidia (p
≤ 0.001). Collectively, these results suggest that D(KLAKLAK)2
has marked fungicidal activity against Mucorales, causing
death of both spores and hyphae; however, its post-antifungal
effect appears more limited.
D(KLAKLAK)2-induced hyphal damage is the result of
plasma membrane depolarization
To determine whether D(KLAKLAK)2 would exert a similar
mechanism of action to that observed in bacteria [23], we
assessed the ability of the peptidomimetic-treated hyphae to
uptake the membrane potential (ΔΨm) -sensitive probe bis-(1,3-
dibutylbarbituric acid) trimethine oxonol (DiBAC), which enters
preferentially depolarized cells [29]. As is true for bacteria,
D(KLAKLAK)2 triggered substantial dye uptake, indicating
Table 1. Minimum inhibitory concentration (MIC) and
minimum fungicidal concentration (MFC) for Mucorales
isolates (µg/ml).
Isolate Test medium
 RPMI 1640 YAG
 MIC MFC MIC MFC
Mucor circinelloides 4030 300 600 600 Not active
Mucor circinelloides 4480 300 600 600 Not active
Mucor circinelloides 5904 300 600 600 Not active
Rhizopus oryzae 3140 300 600 300 Not active
Rhizopus oryzae 4153 300 600 300 Not active
Rhizopus sp. 4523 300 600 300 Not active
Rhizopus homothallicus 5790 300 600 300 Not active
Rhizopus oryzae 5799 300 600 300 Not active
Rhizopus oryzae 6093 300 600 300 Not active
doi: 10.1371/journal.pone.0076981.t001
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increased membrane depolarization; whereas the marker
remained undetected in samples treated with negative controls
such as D(CVRAC) or FLU (Figure 2A).
Because disruption of lipid bilayer integrity is often followed
by release of chemically-stored energy from cells, we
subsequently measured the ATP concentration into the media
Figure 1.  D(KLAKLAK)2 has fungicidal activity against Mucorales.  (A) Micrographs of R. oryzae and M. circinelloides spores
after six hours of exposure to AMB (4 µg/ml), FLU (128 µg/ml), D(KLAKLAK)2 (150 µg/ml, 300 µg/ml) or a negative control
peptidomimetic, D(CVRAC)2 (300 µg/ml), showing that germination was completely inhibited by D(KLAKLAK)2 at MIC (300 µg/ml)and
by AMB (4 µg/ml). Scale bar, 200 µm. (B and C) Mycelia were incubated with AMB (4 µg/ml), FLU (128 µg/ml), D(KLAKLAK)2 (150
µg/ml, 300 µg/ml) or D(CVRAC)2 (300 µg/ml). The extent of hyphal damage was monitored over time by the XTT reduction assay,
which indicated D(KLAKLAK)2-induced dose-dependent killing relative to control drugs (*p ≤ 0.0001). (D and E) Spores were
exposed to AMB (4 µg/ml), FLU (128 µg/ml), D(KLAKLAK)2 (150 µg/ml, 300 µg/ml) or the negative control peptidomimetic (300
µg/ml) for one hour. D(KLAKLAK)2 created a post-antifungal effect demonstrated by a shift of the growth curve to the right compared
to the control drugs. The lag period was increased by approximately three hours (**p ≤ 0.001), followed by a rapid recovery.
doi: 10.1371/journal.pone.0076981.g001
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upon drug treatment [24,29]. We detected rapid (~5 min) and
dose-dependent ATP release similar to that induced by colistin,
an agent known to cause cell membrane disruption (p ≤
0.0002) [24]. The efflux peaked at 30 min of incubation,
followed by a slow decline for both R. oryzae (Figure 2B) and
M. circinelloides (Figure 2C). These results indicate that lipid
bilayer damage accompanied by ΔΨm dissipation sets in upon
exposure to D(KLAKLAK)2.
D(KLAKLAK)2 alters R. oryzae vacuolar homeostasis
and induces mitochondrial swelling
To demonstrate direct plasma membrane structural damage,
we used transmission electron microscopy (TEM) to observe
severe cellular structural damage. In germlings incubated with
either D(KLAKLAK)2 (150-300 µg/ml) or AMB (2 µg/ml),
cytoplasm developed gigantic and abnormally distributed
vacuoles compared to untreated, negative control
Figure 2.  D(KLAKLAK)2 alters plasma membrane homeostasis.  (A) Fluorescence micrographs of R. oryzae and M.
circinelloides mycelia post-exposure to AMB (2 µg/ml), FLU (128 µg/ml), D(KLAKLAK)2 (150 µg/ml, 300 µg/ml) or D(CVRAC)2 (300
µg/ml). The DiBAC bright green fluorescence is indicative of a loss of viability due increased membrane permeability. Differential
interference contrast (DIC) images served as controls for the presence of germlings. Scale bar, 200 µm. (B and C) The dose-
dependent cellular ATP release in the medium after R. oryzae and M. circinelloides hyphae treatment with D(KLAKLAK)2 (150 µg/ml,
300 µg/ml) was similar to that induced by colistin (32 µg/ml) (***p ≤ 0.0002).
doi: 10.1371/journal.pone.0076981.g002
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peptidomimetic- or FLU-treated germlings (Figure 3). Vacuolar
fragmentation is indicative of lipid bilayer damage and likely
impaired trafficking.
To further assess vacuolar injury, we stained mycelia with
the vital dye FM4-64, which stains plasma and vacuolar
membranes [30]. In drug-free and FLU-treated controls, the
marker diffused throughout the plasma membrane revealing
the cell contour (Figure 3) [36]. In contrast, abundant FM4-64
diffused throughout the cytoplasm in D(KLAKLAK)2-exposed
mycelia, suggesting either aggregation and fragmentation or
expansion of vacuoles (Figure 3). At the same time, the
membrane staining was lost likely due to lipid bilayer damage.
In previous work, we showed that upon internalization into
eukaryotic cells, D(KLAKLAK)2 causes lethal mitochondrial
swelling followed by caspase-3 activation and cell apoptosis
[14]. Thus, we reasoned that mitochondrial injury may also be a
major contributor to the fungal susceptibility. To assess
mitochondrial structural changes, we performed MitoTracker
Green FM staining [37], in which the probe accumulates in the
organelle regardless of the ΔΨm. Indeed, in vehicle-
(phosphate-buffered saline, PBS), FLU- and control
peptidomimetic-treated samples, the MitoTracker probe
accumulated in the mitochondria and could be visualized as
round, discrete structures inside the germlings. In contrast, the
mitochondria of AMB and D(KLAKLAK)2-treated cells appeared
to expand throughout the entire cellular content, suggesting
that D(KLAKLAK)2 causes mitochondrial injury and swelling.
D(KLAKLAK)2-induced mitochondrial injury triggers cell
apoptosis
Similar to mammalian cells, augmented ROS levels [31,38],
decreased mitochondrial ΔΨm [33], elevated cytoplasmic
cytochrome c (cyt c) [39] and caspase-like activation of
proteases [40,41] are hallmarks of apoptosis in molds.
Because mitochondria are both a source and a target of ROS
[42], we first examined ROS formation upon D(KLAKLAK)2
treatment. In both R. oryzae and M. circinelloides, germlings
exposed to the peptidomimetic revealed increased intracellular
ROS production as shown by the oxidation of non-fluorescent
dihydrorhodamine 123 (DHR-123) to fluorescent rhodamine
123 (RH-123) [31,38] (Figure 4A). Similar to the respiratory
burst triggered by AMB, quantitative analysis indicated an
approximately 3-fold increase in intracellular ROS
accumulation (Figure 4B) (p ≤ 0.001). In contrast, ROS levels
remained unchanged when germlings were treated with the
negative control peptidomimetic D(CVRAC) (Figure 4 A and B).
Figure 3.  D(KLAKLAK)2 induces ultrastructural cellular changes in R. oryzae.  TEM of germlings (6,000-fold) incubated with
D(KLAKLAK)2 (150 µg/ml, 300 µg/ml) revealed extensive vacuolization comparable to that induced by AMB (2 µg/ml). The increase
in number and size of vacuoles was visualized with the vacuolar probe FM4-64 (red). staining of intact plasma membrane FM4-64
diffusion into the cytoplasm and staining of fragmented vacuoles in treated D(KLAKLAK)2 (150 µg/ml, 300 µg/ml) and AMB (2 µg/ml).
MitoTracker staining (green) indicated morphological changes and swelling of mitochondria in D(KLAKLAK)2-exposed germlings as
opposed to the punctate pattern observed in samples treated with control drugs. TEM scale bar, 2 µm. Fluorescent micrographs
scale bar, 200 µm.
doi: 10.1371/journal.pone.0076981.g003
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N-acetyl cysteine (NAC), an ROS scavenger [31], restored
normal ROS levels (Figure 4 A and B).
We also compared the mitochondrial ΔΨm of R. oryzae and
M. circinelloides germlings exposed to D(KLAKLAK)2 or the
negative control peptidomimetic by using RH-123, a cationic
dye that distributes electrophoretically within the mitochondrial
membrane as a consequence of its electric potential [33].
Consistent with our mechanistic hypothesis, D(KLAKLAK)2
treatment reduced the ΔΨm and increased membrane
depolarization of both R. oryzae and M. circinelloides
germlings, as demonstrated by the accumulation of RH-123
(Figure 5 A and B). The mean relative fluorescence intensity
was nearly 2.4-fold higher in samples treated with
D(KLAKLAK)2 compared to germlings treated with controls
(Figure 5 A and B) (p ≤ 0.001). The homeostatic ΔΨm was
again restored by the addition of NAC (Figure 5 A and B).
To further demonstrate that D(KLAKLAK)2-induced
mitochondrial injury triggers apoptosis, we examined
Figure 4.  Exposure to D(KLAKLAK)2 triggers intracellular ROS accumulation.  (A) Fluorescence and DIC micrographs of R.
oryzae and M. circinelloides germlings stained with the oxidation-sensitive dye DHR-123, showing ROS production after incubation
with D(KLAKLAK)2 (150 µg/ml) or AMB (2 µg/ml). Scale bar, 200 µm. (B) Quantitative analysis recorded with a microplate reader
(excitation, 488 nm; emission, 525 nm), demonstrating a significant increase in ROS release from mitochondria in the presence of
D(KLAKLAK)2 (**p ≤ 0.001) relative to FLU (128 µg/ml) or negative control peptidomimetic (300 µg/ml).
doi: 10.1371/journal.pone.0076981.g004
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translocation of cyt c from mitochondrial cristae into the cytosol,
which is a critical event in apoptosis [39]. We detected an
approximately 3-fold increase of cyt c levels in the mitochondria
and cytosol of R. oryzae and M. circinelloides germlings treated
with D(KLAKLAK)2 relative to samples treated with the negative
control peptidomimetic (Figure 6A) (p ≤ 0.001).
Similar to mammalian cells, the fungal apoptotic process is
accompanied by activation of caspase-like cysteine proteases,
referred to as metacaspases [40,41]. To further corroborate our
results, we evaluated the activation of these enzymes in both
R. oryzae and M. circinelloides germlings treated with
D(KLAKLAK)2 by using an in situ marker, CaspACE FITC-VAD-
FMK, which is a fluorescently-labeled compound that
Figure 5.  D(KLAKLAK)2 induces mitochondrial membrane depolarization (ΔΨm).  (A) Fluorescence and DIC micrographs of R.
oryzae and M. circinelloides germlings stained with the oxidation-sensitive dye RH-123, indicating membrane depolarization after
incubation with D(KLAKLAK)2 (150 µg/ml) or AMB (2 µg/ml). Scale bar, 200 µm. (B) Quantitative analysis recorded with a microplate
reader (excitation, 488 nm; emission, 525 nm), demonstrating significant membrane depolarization levels (**p ≤ 0.001), post-
exposure to D(KLAKLAK)2 compared to FLU (128 µg/ml) or the negative control peptidomimetic (300 µg/ml).
doi: 10.1371/journal.pone.0076981.g005
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Figure 6.  D(KLAKLAK)2 causes Mucorales apoptosis.  (A) Relative quantification indicated significantly higher levels (**p ≤
0.001) of cytochrome c release from mitochondria of R. oryzae and M. circinelloides into the cytosol in the presence of D(KLAKLAK)2
(150 µg/ml) relative to FLU (128 µg/ml) or the negative control peptidomimetic (300 µg/ml). (B) Fluorescence and DIC micrographs
of R. oryzae and M. circinelloides germlings stained with the CaspACE FITC-VAD-FMK In Situ Marker, indicating metacaspase
activation upon incubation with D(KLAKLAK)2 (150 µg/ml) compared to FLU (128 µg/ml) or the negative control peptidomimetic (300
µg/ml). Scale bar, 200 µm. (C) Fluorescence quantitative analysis of R. oryzae and M. circinelloides germlings in the presence of
drugs revealed significant levels of metacaspase activation in germlings treated with D(KLAKLAK)2 (**p ≤ 0.001).
doi: 10.1371/journal.pone.0076981.g006
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irreversibly binds to activated caspases [35]. Germlings treated
with D(KLAKLAK)2 exhibited enzymatic activity as shown by
fluorescent micrographs and quantitative analysis (Figure 6 B
and C). In contrast, metacaspase levels remained undetected
in germlings treated with the negative control peptidomimetic
D(CVRAC). As expected, R. oryzae and M. circinelloides
germlings pretreatment with the ROS scavenger NAC
prevented activation of metacaspases (Figure 6 B and C).
Given that caspases play a central role in the apoptotic
cascade [40], these results further support the conclusion that
D(KLAKLAK)2-induced mitochondrial damage elicits cell
apoptosis and death. Precisely why AMB, which also affects
mitochondrial membrane, does not induce apoptosis is unclear.
It is possible that the antifungal mechanism of AMB activity
relies mostly on plasma membrane damage, and that
mitochondrial membrane damage is not as extensive; however,
our methods were not as sophisticated to dissect this subtle
changes. Alternatively, D(KLAKLAK)2-induced apoptotic
process is only in part due to the mitochondrial membrane
damage.
Conclusions
In summary, these results show that the prototype
D(KLAKLAK)2 acts as a growth proliferation inhibitor in vitro
against Mucorales. These findings support our previous studies
that this all-D-enantiomer antimicrobial peptidomimetic
functions through a plasma membrane-disruptive mechanism
[22,23]. Similar to other ligand-directed D(KLAKLAK)2 –
containing peptidomimetics being evaluated as vascular-
targeted drug candidates against cancer and obesity [14-22],
untargeted D(KLAKLAK)2 enters the cell and triggers
mitochondrial membrane depolarization and swelling, ultimately
resulting in apoptosis and fungal death.
Mitochondria are well-known to play an important
mechanistic role in the apoptotic death of C. albicans, A.
fumigatus, and A. flavus treated with compounds such as
plagiochin E or farnesol [33,42-45]. As hyperbaric oxygen
potentiates the effect of antifungals [46], perhaps through
accelerated induction of apoptosis [47], mitochondrial injury
might indeed be the proverbial Achilles’ heel in Mucorales
susceptibility. Indeed, we have recently shown that the
combined inhibition of ergosterol synthesis and mitochondrial
respiration results in accelerated apoptotic death [32]. One can
speculate that D(KLAKLAK)2 or an optimized drug derivative
may also have desirable therapeutic effects for therapy in
combination with conventional antifungals.
Of note, we have previously reported a ligand peptide that
binds to the cell surface of A. fumigatus both in vitro and in lung
tissue in an experimental mouse model of invasive pulmonary
aspergillosis [48]. Thus, we would anticipate that D(KLAKLAK)2
may perhaps be synthesized in tandem to Mucorales-targeting
ligand motifs for potentially improved activity and decreased
toxicity. In addition to favorable tissue permeability and
biodistribution associated with small molecules, resistance to
proteolysis may improve bioavailability and cost-effectiveness.
It remains to be determined whether or not the prototype
proposed here retains efficacy and is nontoxic in vivo,
particularly in the setting of severe fungal infections in
immunosuppressed patients; however toxicology studies of
targeted D(KLAKLAK)2-containing drugs yielded predictable and
reversible drug-induced toxicity at therapeutic concentrations
[19-21]. Given the lack of good treatment options against
mucormycosis, the results reported here raise the prospect for
further preclinical studies to evaluate this class of
antimicrobials for translational drug development.
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